Anaphylaxis is an acute, life-threatening systemic hypersensitivity reaction requiring immediate recognition and intervention. Prompt intramuscular administration of adrenaline remains the cornerstone ...
The new guidelines reflect the efforts of a 46-member panel of experts from 14 countries and seven medical specialties. The findings have received endorsements from 34 medical and patient advocacy ...
Please provide your email address to receive an email when new articles are posted on . 23.7% of respondents said they would first use antihistamines for anaphylaxis. The top barrier to epinephrine ...
Misinformation and outdated protocols contribute to the suboptimal management of anaphylaxis by patients and healthcare professionals, based on data from two new studies presented at the American ...
A groundbreaking consensus report on anaphylaxis – the severe reaction some people experience from bee stings, peanut butter exposures, medications, and the like – has been released by the Global ...
Kaléo, a global leader in drug-delivery device combinations and auto-injector innovation and the makers of the only epinephrine auto-injector with voice guidance, AUVI-Q ® (epinephrine injection), ...
AllergyAware e-learning course significantly improved school personnel's anaphylaxis knowledge and confidence in using epinephrine auto-injectors. Food allergies increase anaphylaxis risk, impacting ...
Zacks Small Cap Research on MSN
NSRX: Initiating coverage – sniffing out a better solution
By John Vandermosten, CFA NYSE:NSRX READ THE FULL NSRX INITIATION RESEARCH REPORT We are initiating coverage of Nasus Pharma Ltd. (NYSE:NSRX) with a valuation of $19.00 per share. This value is based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results